{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:00:22Z","timestamp":1787162422691,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Technology Innovation Team of Jiangxi University of Chinese Medicine","award":["CXTD 220090"],"award-info":[{"award-number":["CXTD 220090"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-04107-z","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T22:16:42Z","timestamp":1744064202000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Potential drugs associated with toxic epidermal necrolysis: a disproportionality analysis based on the FAERS database (2004\u20132024)"],"prefix":"10.1007","volume":"317","author":[{"given":"Xiaojian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangren","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunbo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guirong","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,29]]},"reference":[{"issue":"7","key":"4107_CR1","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1089\/wound.2019.0977","volume":"9","author":"OA Charlton","year":"2020","unstructured":"Charlton OA, Harris V, Phan K, Mewton E, Jackson C, Cooper A (2020) Toxic epidermal necrolysis and Steven-Johnson syndrome: A comprehensive review. Adv Wound Care (New Rochelle) 9(7):426\u2013439. https:\/\/doi.org\/10.1089\/wound.2019.0977","journal-title":"Adv Wound Care (New Rochelle)"},{"issue":"7","key":"4107_CR2","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1212\/01.WNL.0000156354.20227.F0","volume":"64","author":"M Mockenhaupt","year":"2005","unstructured":"Mockenhaupt M, Messenheimer J, Tennis P, Schlingmann J (2005) Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. Neurology 64(7):1134\u20131138. https:\/\/doi.org\/10.1212\/01.WNL.0000156354.20227.F0","journal-title":"Neurology"},{"key":"4107_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1750-1172-5-39","volume":"5","author":"T Harr","year":"2010","unstructured":"Harr T, French LE (2010) Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis 5:39 Published 2010 Dec 16. https:\/\/doi.org\/10.1186\/1750-1172-5-39","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"4107_CR4","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.2217\/14622416.9.10.1543","volume":"9","author":"PB Ferrell Jr","year":"2008","unstructured":"Ferrell PB Jr, McLeod HL, Carbamazepine (2008) HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations. Pharmacogenomics 9(10):1543\u20131546. https:\/\/doi.org\/10.2217\/14622416.9.10.1543","journal-title":"Pharmacogenomics"},{"issue":"2","key":"4107_CR5","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jaip.2020.09.021","volume":"9","author":"RJ Yu","year":"2021","unstructured":"Yu RJ, Krantz MS, Phillips EJ, Stone CA Jr. (2021) Emerging causes of Drug-Induced anaphylaxis: A review of Anaphylaxis-Associated reports in the FDA adverse event reporting system (FAERS). J Allergy Clin Immunol Pract 9(2):819\u2013829e2. https:\/\/doi.org\/10.1016\/j.jaip.2020.09.021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"4107_CR6","doi-asserted-by":"publisher","unstructured":"Zou F, Cui Z, Lou S et al (2024) Adverse drug events associated with linezolid administration: a real-world pharmacovigilance study from 2004 to 2023 using the FAERS database. Front Pharmacol.;15:1338902. Published 2024 Feb 16. https:\/\/doi.org\/10.3389\/fphar.2024.1338902","DOI":"10.3389\/fphar.2024.1338902"},{"issue":"5","key":"4107_CR7","first-page":"7","volume":"27","author":"N Singh","year":"2022","unstructured":"Singh N, Phillips M (2022) Toxic epidermal necrolysis: A review of past and present therapeutic approaches. Skin Therapy Lett 27(5):7\u201313","journal-title":"Skin Therapy Lett"},{"issue":"11","key":"4107_CR8","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.36849\/JDD.6999","volume":"22","author":"S Meledathu","year":"2023","unstructured":"Meledathu S, Gordon M, Thornton M, Ashinoff R (2023) Management of Stevens-Johnson syndrome\/toxic epidermal necrolysis: A case report and literature review. J Drugs Dermatol 22(11):e24\u2013e28. https:\/\/doi.org\/10.36849\/JDD.6999","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"4107_CR9","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1001\/jamadermatol.2022.6378","volume":"159","author":"EY Lee","year":"2023","unstructured":"Lee EY, Knox C, Phillips EJ (2023) Worldwide prevalence of Antibiotic-Associated Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review and Meta-analysis. JAMA Dermatol 159(4):384\u2013392. https:\/\/doi.org\/10.1001\/jamadermatol.2022.6378","journal-title":"JAMA Dermatol"},{"issue":"10","key":"4107_CR10","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1111\/ddg.15150","volume":"21","author":"W Wu","year":"2023","unstructured":"Wu W, Da M, Chen M et al (2023) Toxic epidermal necrolysis post apalutamide with preceding Tislelizumab administration in a patient with two cancers. J Dtsch Dermatol Ges 21(10):1221\u20131223. https:\/\/doi.org\/10.1111\/ddg.15150","journal-title":"J Dtsch Dermatol Ges"},{"key":"4107_CR11","doi-asserted-by":"publisher","unstructured":"Loft JA, Riis PT, Schultz NA et al (2024) Maribavir for treatment of cytomegalovirus infection in a liver-transplanted patient. Ugeskr Laeger.;186(15):V11230726. Published 2024 Apr 8. https:\/\/doi.org\/10.61409\/V11230726","DOI":"10.61409\/V11230726"},{"issue":"2","key":"4107_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.alit.2020.11.004","volume":"70","author":"T Watanabe","year":"2021","unstructured":"Watanabe T, Go H, Saigusa Y et al (2021) Mortality and risk factors on admission in toxic epidermal necrolysis: A cohort study of 59 patients. Allergol Int 70(2):229\u2013234. https:\/\/doi.org\/10.1016\/j.alit.2020.11.004","journal-title":"Allergol Int"},{"issue":"6","key":"4107_CR13","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.clindermatol.2020.06.016","volume":"38","author":"MH Noe","year":"2020","unstructured":"Noe MH, Micheletti RG (2020) Diagnosis and management of Stevens-Johnson syndrome\/toxic epidermal necrolysis. Clin Dermatol 38(6):607\u2013612. https:\/\/doi.org\/10.1016\/j.clindermatol.2020.06.016","journal-title":"Clin Dermatol"},{"key":"4107_CR14","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.amsu.2020.11.036","volume":"60","author":"KK Kc","year":"2020","unstructured":"Kc KK, Limbu T, Maskay SS, Bhasima A, Acharya SP (2020) Lamotrigine induced toxic epidermal necrolysis: A case report. Ann Med Surg (Lond) 60:468\u2013470 Published 2020 Nov 17. https:\/\/doi.org\/10.1016\/j.amsu.2020.11.036","journal-title":"Ann Med Surg (Lond)"},{"issue":"6","key":"4107_CR15","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.12669\/pjms.39.6.7513","volume":"39","author":"O Farooq","year":"2023","unstructured":"Farooq O, Abbas A, Ahmad M, Manzoor AB (2023) Lamotrigine-associated toxic epidermal necrolysis. Pak J Med Sci 39(6):1883\u20131886. https:\/\/doi.org\/10.12669\/pjms.39.6.7513","journal-title":"Pak J Med Sci"},{"issue":"7","key":"4107_CR16","doi-asserted-by":"publisher","first-page":"e42654","DOI":"10.7759\/cureus.42654","volume":"15","author":"MN Tunuguntla","year":"2023","unstructured":"Tunuguntla MN, Chanti P, Kesani T, Yarapathineni K, Kukkadapu P (2023) Phenytoin-Induced toxic epidermal necrolysis. Cureus 15(7):e42654 Published 2023 Jul 29. https:\/\/doi.org\/10.7759\/cureus.42654","journal-title":"Cureus"},{"issue":"11","key":"4107_CR17","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/all.13821","volume":"74","author":"M Mockenhaupt","year":"2019","unstructured":"Mockenhaupt M, Wang CW, Hung SI et al (2019) HLA-B*57:01 confers genetic susceptibility to carbamazepine-induced SJS\/TEN in Europeans. Allergy 74(11):2227\u20132230. https:\/\/doi.org\/10.1111\/all.13821","journal-title":"Allergy"},{"issue":"9","key":"4107_CR18","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1001\/jamadermatol.2013.4114","volume":"149","author":"W Tangamornsuksan","year":"2013","unstructured":"Tangamornsuksan W, Chaiyakunapruk N, Somkrua R, Lohitnavy M, Tassaneeyakul W (2013) Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. JAMA Dermatol 149(9):1025\u20131032. https:\/\/doi.org\/10.1001\/jamadermatol.2013.4114","journal-title":"JAMA Dermatol"},{"issue":"4","key":"4107_CR19","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/pde.14179","volume":"37","author":"A Est\u00e9banez","year":"2020","unstructured":"Est\u00e9banez A, S\u00e1ez-Mart\u00edn LC, Mu\u00f1oz JI et al (2020) Levetiracetam-induced pediatric toxic epidermal necrolysis successfully treated with etanercept. Pediatr Dermatol 37(4):701\u2013705. https:\/\/doi.org\/10.1111\/pde.14179","journal-title":"Pediatr Dermatol"},{"issue":"9","key":"4107_CR20","doi-asserted-by":"publisher","first-page":"e45334","DOI":"10.7759\/cureus.45334","volume":"15","author":"H Liu","year":"2023","unstructured":"Liu H, Yang J, Liu R (2023) A case of toxic epidermal necrolysis caused by lamotrigine combined with valproic acid and literature review. Cureus 15(9):e45334. https:\/\/doi.org\/10.7759\/cureus.45334. Published 2023 Sep 16","journal-title":"Cureus"},{"issue":"5","key":"4107_CR21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.4103\/0019-5154.117319","volume":"58","author":"S Kaur","year":"2013","unstructured":"Kaur S, Dogra A (2013) Toxic epidermal necrolysis due to concomitant use of lamotrigine and valproic acid. Indian J Dermatol 58(5):406. https:\/\/doi.org\/10.4103\/0019-5154.117319","journal-title":"Indian J Dermatol"},{"issue":"4","key":"4107_CR22","doi-asserted-by":"publisher","first-page":"e231","DOI":"10.1111\/ijd.16584","volume":"62","author":"G Almuhana","year":"2023","unstructured":"Almuhana G, Alsalhi A, Alsalhi H, Al-Hoqail IA (2023) New insight into the management of toxic epidermal necrolysis following the coadministration of lamotrigine and valproic acid. Int J Dermatol 62(4):e231\u2013e233. https:\/\/doi.org\/10.1111\/ijd.16584","journal-title":"Int J Dermatol"},{"issue":"12","key":"4107_CR23","doi-asserted-by":"publisher","first-page":"e6766","DOI":"10.1002\/ccr3.6766","volume":"10","author":"B Dhakal","year":"2022","unstructured":"Dhakal B, Dawadi S, Khadka L et al (2022) Ciprofloxacin induced toxic epidermal necrolysis with cholestatic hepatitis: A case report with literature review and revisit to the Naranjo adverse drug reaction probability scale. Clin Case Rep 10(12):e6766 Published 2022 Dec 20. https:\/\/doi.org\/10.1002\/ccr3.6766","journal-title":"Clin Case Rep"},{"issue":"5","key":"4107_CR24","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1001\/jamadermatol.2024.0210","volume":"160","author":"PC Wu","year":"2024","unstructured":"Wu PC, Chen WT, Huang IH et al (2024) Human leukocyte antigens and Sulfamethoxazole\/Cotrimoxazole-Induced severe cutaneous adverse reactions: A systematic review and Meta-Analysis. JAMA Dermatol 160(5):525\u2013534. https:\/\/doi.org\/10.1001\/jamadermatol.2024.0210","journal-title":"JAMA Dermatol"},{"issue":"2","key":"4107_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/1120009X.2022.2051128","volume":"35","author":"AV Pejcic","year":"2023","unstructured":"Pejcic AV, Milosavljevic MN, Folic M et al (2023) Amoxicillin-associated Stevens-Johnson syndrome or toxic epidermal necrolysis: systematic review. J Chemother 35(2):75\u201386. https:\/\/doi.org\/10.1080\/1120009X.2022.2051128","journal-title":"J Chemother"},{"issue":"6","key":"4107_CR26","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1097\/00007611-199006000-00035","volume":"83","author":"BA Hannah","year":"1990","unstructured":"Hannah BA, Kimmel PL, Dosa S, Turner ML (1990) Vancomycin-induced toxic epidermal necrolysis. South Med J 83(6):720\u2013722. https:\/\/doi.org\/10.1097\/00007611-199006000-00035","journal-title":"South Med J"},{"key":"4107_CR27","doi-asserted-by":"publisher","first-page":"9323","DOI":"10.1186\/1752-1947-3-9323","volume":"3","author":"S Cohen","year":"2009","unstructured":"Cohen S, Billig A, Ad-El D (2009) Ceftriaxone-induced toxic epidermal necrolysis mimicking burn injury: a case report. J Med Case Rep 3:9323 Published 2009 Dec 10. https:\/\/doi.org\/10.1186\/1752-1947-3-9323","journal-title":"J Med Case Rep"},{"issue":"3","key":"4107_CR28","doi-asserted-by":"crossref","first-page":"676e","DOI":"10.1016\/j.ajem.2015.06.039","volume":"34","author":"TM Nappe","year":"2016","unstructured":"Nappe TM, Goren-Garcia SL, Jacoby JL (2016) Stevens-Johnson syndrome after treatment with Azithromycin: an uncommon culprit. Am J Emerg Med 34(3):676e. 1-676.e6763","journal-title":"Am J Emerg Med"},{"issue":"3","key":"4107_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/ced.13030","volume":"42","author":"NR Adler","year":"2017","unstructured":"Adler NR, McLean CA, Aung AK, Goh MS (2017) Piperacillin-tazobactam-induced linear IgA bullous dermatosis presenting clinically as Stevens-Johnson syndrome\/toxic epidermal necrolysis overlap. Clin Exp Dermatol 42(3):299\u2013302. https:\/\/doi.org\/10.1111\/ced.13030","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"4107_CR30","doi-asserted-by":"publisher","first-page":"e39504","DOI":"10.7759\/cureus.39504","volume":"15","author":"AA Khan","year":"2023","unstructured":"Khan AA, Aisha U, Hassan A, Haider Z, Cook DE (2023) Levofloxacin-Induced toxic epidermal necrolysis. Cureus 15(5):e39504 Published 2023 May 25. https:\/\/doi.org\/10.7759\/cureus.39504","journal-title":"Cureus"},{"issue":"12","key":"4107_CR31","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.clinthera.2024.09.014","volume":"46","author":"X Wang","year":"2024","unstructured":"Wang X, Cheng G, Liang X et al (2024) Toxic epidermal necrolysis observed in a patient with the HLA-B*1502 treated with Levofloxacin. Clin Ther 46(12):1082\u20131085. https:\/\/doi.org\/10.1016\/j.clinthera.2024.09.014","journal-title":"Clin Ther"},{"issue":"1","key":"4107_CR32","doi-asserted-by":"publisher","first-page":"70","DOI":"10.5415\/apallergy.2016.6.1.70","volume":"6","author":"SS Angadi","year":"2016","unstructured":"Angadi SS, Karn A (2016) Ibuprofen induced Stevens-Johnson syndrome - toxic epidermal necrolysis in Nepal. Asia Pac Allergy 6(1):70\u201373. https:\/\/doi.org\/10.5415\/apallergy.2016.6.1.70","journal-title":"Asia Pac Allergy"},{"issue":"1","key":"4107_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3166\/bspe-2018-0009","volume":"111","author":"GI Bi","year":"2018","unstructured":"Bi GI, Pete Y, Kamagate M et al (2018) Syndrome de Lyell d\u2019\u00e9volution fatale suite \u00e0 La r\u00e9administration de Diclof\u00e9nac, Au CHU de Bouak\u00e9 (C\u00f4te d\u2019Ivoire) [Fatal Toxic Epidermal Necrolysis Induced by Diclofenac Re-Administration in the Teaching Hospital of Bouak\u00e9 (C\u00f4te d\u2019Ivoire)]. Bull Soc Pathol Exot 111(1):9\u201311. https:\/\/doi.org\/10.3166\/bspe-2018-0009","journal-title":"Bull Soc Pathol Exot"},{"key":"4107_CR34","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.3332\/ecancer.2020.1010","volume":"14","author":"G Eichhoff","year":"2020","unstructured":"Eichhoff G (2020) Slowly developing toxic epidermal necrolysis-like reaction associated with pemetrexed and carboplatin. Ecancermedicalscience 14:1010 Published 2020 Feb 13. https:\/\/doi.org\/10.3332\/ecancer.2020.1010","journal-title":"Ecancermedicalscience"},{"issue":"6","key":"4107_CR35","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ad.2012.11.017","volume":"105","author":"L Puig","year":"2014","unstructured":"Puig L (2014) Methotrexate: new therapeutic approaches. Actas Dermosifiliogr 105(6):583\u2013589. https:\/\/doi.org\/10.1016\/j.ad.2012.11.017","journal-title":"Actas Dermosifiliogr"},{"issue":"2","key":"4107_CR36","doi-asserted-by":"publisher","first-page":"263","DOI":"10.23736\/S2784-8671.20.06621-3","volume":"156","author":"H Li","year":"2021","unstructured":"Li H, Zhang J, Chen Y (2021) Methotrexate-induced toxic epidermal necrolysis in a child undergoing a combination therapy for systemic lupus erythematosus. Ital J Dermatol Venerol 156(2):263\u2013264. https:\/\/doi.org\/10.23736\/S2784-8671.20.06621-3","journal-title":"Ital J Dermatol Venerol"},{"issue":"11","key":"4107_CR37","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1080\/21645515.2016.1199310","volume":"12","author":"G Kwok","year":"2016","unstructured":"Kwok G, Yau TC, Chiu JW, Tse E, Kwong YL (2016) Pembrolizumab (Keytruda). Hum Vaccin Immunother 12(11):2777\u20132789. https:\/\/doi.org\/10.1080\/21645515.2016.1199310","journal-title":"Hum Vaccin Immunother"},{"issue":"16","key":"4107_CR38","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1158\/1078-0432.CCR-15-2872","volume":"22","author":"SM Goldinger","year":"2016","unstructured":"Goldinger SM, Stieger P, Meier B et al (2016) Cytotoxic cutaneous adverse drug reactions during Anti-PD-1 therapy. Clin Cancer Res 22(16):4023\u20134029. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-2872","journal-title":"Clin Cancer Res"},{"issue":"3","key":"4107_CR39","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1159\/000526931","volume":"15","author":"L Borg","year":"2022","unstructured":"Borg L, Buhagiar M, La Ferla E, Pisani D, Said J, Boffa MJ (2022) Pembrolizumab-Induced toxic epidermal necrolysis. Case Rep Oncol 15(3):887\u2013893 Published 2022 Oct 3. https:\/\/doi.org\/10.1159\/000526931","journal-title":"Case Rep Oncol"},{"issue":"1","key":"4107_CR40","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2174\/1574886318666230224092818","volume":"19","author":"M Daldoul","year":"2024","unstructured":"Daldoul M, Charfi O, Bouattour E et al (2024) Pantoprazole-induced Stevens-Johnson syndrome: A Case-report. Curr Drug Saf 19(1):148\u2013150. https:\/\/doi.org\/10.2174\/1574886318666230224092818","journal-title":"Curr Drug Saf"},{"issue":"6","key":"4107_CR41","first-page":"699","volume":"16","author":"M Casacci","year":"2006","unstructured":"Casacci M, Lebas D, Decamps F, Fourrier F, Delaporte E (2006) Toxic epidermal necrolysis due to Omeprazole. Eur J Dermatol 16(6):699\u2013700","journal-title":"Eur J Dermatol"},{"issue":"3","key":"4107_CR42","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1590\/abd1806-4841.20132636","volume":"88","author":"CM Gomes","year":"2013","unstructured":"Gomes CM (2013) Toxic epidermal necrolysis induced by Lansoprazole: Pharmacologic considerations. Bras Dermatol 88(3):485. https:\/\/doi.org\/10.1590\/abd1806-4841.20132636","journal-title":"Bras Dermatol"},{"issue":"5","key":"4107_CR43","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1097\/BCR.0b013e31822ac7be","volume":"32","author":"BE Baetz","year":"2011","unstructured":"Baetz BE, Patton ML, Guilday RE, Reigart CL, Ackerman BH (2011) Amlodipine-induced toxic epidermal necrolysis. J Burn Care Res 32(5):e158\u2013e160. https:\/\/doi.org\/10.1097\/BCR.0b013e31822ac7be","journal-title":"J Burn Care Res"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04107-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-04107-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04107-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T22:16:44Z","timestamp":1744064204000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-04107-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,29]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4107"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-04107-z","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,29]]},"assertion":[{"value":"15 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"647"}}